Expression of wild-type and truncated myocilins in trabecular meshwork cells: their subcellular localizations and cytotoxicities - PubMed (original) (raw)

. 2002 Dec;43(12):3680-5.

Affiliations

PMID: 12454036

Expression of wild-type and truncated myocilins in trabecular meshwork cells: their subcellular localizations and cytotoxicities

Seongsoo Sohn et al. Invest Ophthalmol Vis Sci. 2002 Dec.

Abstract

Purpose: To investigate the subcellular localizations and potential cytotoxicities of wild-type and truncated (Q368X) myocilin in cultured human trabecular meshwork (TM) cells.

Methods: Full-length wild-type myocilin, truncated myocilin, and stromelysin were expressed as green fluorescence (GFP) or DsRed fusion proteins in TM cells by using adenoviral vectors, and their secretory properties and cytopathic effects were evaluated by Western blot analysis and cell proliferation assay, respectively. To determine the subcellular localizations of myocilins, the cellular organelles of the infected TM cells were stained with organelle-specific antibodies or fluorescent indicators and examined under a confocal microscope.

Results: Wild-type myocilin was expressed mainly in the perinuclear region of TM cells and was localized preferentially in endoplasmic reticulum (ER), but not in actin, microtubules, or mitochondria. Truncated myocilin was also localized in ER, and its expression was found to be potentially toxic to TM cells, leading to deformed cellular morphology and diminished cell proliferation, but it had no effect on the secretion of stromelysin. The truncated myocilin was also found to be colocalized with and appeared to aggregate with wild-type myocilin when the proteins were coexpressed.

Conclusions: TM cells participating in the turnover of trabecular extracellular matrix (ECM) components are important in regulating aqueous outflow. The truncated myocilin, colocalized and coaggregated with wild-type myocilin, is believed to cause a dysfunction of the cells, resulting in alterations in structural compartmentalization of trabecular ECM and obstruction of aqueous outflow.

PubMed Disclaimer

Cited by

Dual localization of wild-type myocilin in the endoplasmic reticulum and extracellular compartment likely occurs due to its incomplete secretion.
Sohn S, Joe MK, Kim TE, Im JE, Choi YR, Park H, Kee C. Sohn S, et al. Mol Vis. 2009;15:545-56. Epub 2009 Mar 13. Mol Vis. 2009. PMID: 19287508 Free PMC article.
Two-photon immunofluorescence characterization of the trabecular meshwork in situ.
Gonzalez JM Jr, Heur M, Tan JC. Gonzalez JM Jr, et al. Invest Ophthalmol Vis Sci. 2012 Jun 5;53(7):3395-404. doi: 10.1167/iovs.11-8570. Invest Ophthalmol Vis Sci. 2012. PMID: 22531697 Free PMC article.
Protein quality control: the who's who, the where's and therapeutic escapes.
Roth J, Yam GH, Fan J, Hirano K, Gaplovska-Kysela K, Le Fourn V, Guhl B, Santimaria R, Torossi T, Ziak M, Zuber C. Roth J, et al. Histochem Cell Biol. 2008 Feb;129(2):163-77. doi: 10.1007/s00418-007-0366-7. Epub 2007 Dec 13. Histochem Cell Biol. 2008. PMID: 18075753 Free PMC article. Review.
Myocilin interacts with syntrophins and is member of dystrophin-associated protein complex.
Joe MK, Kee C, Tomarev SI. Joe MK, et al. J Biol Chem. 2012 Apr 13;287(16):13216-27. doi: 10.1074/jbc.M111.224063. Epub 2012 Feb 25. J Biol Chem. 2012. PMID: 22371502 Free PMC article.
Characterization of monoclonal antibodies against the glaucoma-associated protein myocilin.
Ezzat MK, Howell KG, Bahler CK, Beito TG, Loewen N, Poeschla EM, Fautsch MP. Ezzat MK, et al. Exp Eye Res. 2008 Oct;87(4):376-84. doi: 10.1016/j.exer.2008.07.002. Epub 2008 Jul 12. Exp Eye Res. 2008. PMID: 18674535 Free PMC article.

Expression of wild-type and truncated myocilins in trabecular meshwork cells: their subcellular localizations and cytotoxicities - PubMed (original) (raw)